ArticleMalaria journal2012

Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.

Aurélie Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.